ID SSR2_MOUSE Reviewed; 369 AA. AC P30875; P30934; Q91Y73; DT 01-JUL-1993, integrated into UniProtKB/Swiss-Prot. DT 01-JUL-1993, sequence version 1. DT 27-MAR-2024, entry version 193. DE RecName: Full=Somatostatin receptor type 2; DE Short=SS-2-R; DE Short=SS2-R; DE Short=SS2R; DE AltName: Full=SRIF-1; GN Name=Sstr2; Synonyms=Smstr2, Sst2; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM A). RX PubMed=1346068; DOI=10.1073/pnas.89.1.251; RA Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S.; RT "Cloning and functional characterization of a family of human and mouse RT somatostatin receptors expressed in brain, gastrointestinal tract, and RT kidney."; RL Proc. Natl. Acad. Sci. U.S.A. 89:251-255(1992). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM B). RX PubMed=1397330; DOI=10.1016/0014-5793(92)81122-3; RA Vanetti M., Kouba M., Wang X., Vogt G., Hoellt V.; RT "Cloning and expression of a novel mouse somatostatin receptor (SSTR2B)."; RL FEBS Lett. 311:290-294(1992). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND ALTERNATIVE SPLICING (ISOFORMS A AND RP B). RC STRAIN=129; TISSUE=Liver; RX PubMed=11278805; DOI=10.1074/jbc.m010981200; RA Puente E., Saint-Laurent N., Torrisani J., Furet C., Schally A.V., RA Vaysse N., Buscail L., Susini C.; RT "Transcriptional activation of mouse sst2 somatostatin receptor promoter by RT transforming growth factor-beta. Involvement of Smad4."; RL J. Biol. Chem. 276:13461-13468(2001). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 99-309 (ISOFORMS A/B). RX PubMed=7913111; RA Elliott D.E., Metwali A., Blum A.M., Sandor M., Lynch R., Weinstock J.V.; RT "T lymphocytes isolated from the hepatic granulomas of schistosome-infected RT mice express somatostatin receptor subtype II (SSTR2) messenger RNA."; RL J. Immunol. 153:1180-1186(1994). RN [5] RP FUNCTION, SUBCELLULAR LOCATION, AND ALTERNATIVE SPLICING (ISOFORMS A AND RP B). RX PubMed=8104154; DOI=10.1016/0014-5793(93)80349-y; RA Vanetti M., Hoellt V.; RT "The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) RT differ in coupling efficiency to adenylate cyclase and in agonist-induced RT receptor desensitization."; RL FEBS Lett. 331:260-266(1993). RN [6] RP FUNCTION. RX PubMed=9507021; DOI=10.1074/jbc.273.12.7099; RA Bousquet C., Delesque N., Lopez F., Saint-Laurent N., Esteve J.P., RA Bedecs K., Buscail L., Vaysse N., Susini C.; RT "sst2 somatostatin receptor mediates negative regulation of insulin RT receptor signaling through the tyrosine phosphatase SHP-1."; RL J. Biol. Chem. 273:7099-7106(1998). CC -!- FUNCTION: Receptor for somatostatin-14 and -28. This receptor is CC coupled via pertussis toxin sensitive G proteins to inhibition of CC adenylyl cyclase. In addition it stimulates phosphotyrosine phosphatase CC and PLC via pertussis toxin insensitive as well as sensitive G CC proteins. Inhibits calcium entry by suppressing voltage-dependent CC calcium channels. Acts as the functionally dominant somatostatin CC receptor in pancreatic alpha- and beta-cells where it mediates the CC inhibitory effect of somatostatin-14 on hormone secretion. Inhibits CC cell growth through enhancement of MAPK1 and MAPK2 phosphorylation and CC subsequent up-regulation of CDKN1B. Stimulates neuronal migration and CC axon outgrowth and may participate in neuron development and maturation CC during brain development. Mediates negative regulation of insulin CC receptor signaling through PTPN6. Inactivates SSTR3 receptor function CC following heterodimerization. {ECO:0000269|PubMed:8104154, CC ECO:0000269|PubMed:9507021}. CC -!- SUBUNIT: Homodimer and heterodimer with SSTR3 and SSTR5. CC Heterodimerization with SSTR3 inactivates SSTR3 receptor function. CC Heterodimerization with SSTR5 is enhanced by agonist stimulation of CC SSTR2 and increases SSTR2 cell growth inhibition activity. Following CC agonist stimulation, homodimers dissociate into monomers which is CC required for receptor internalization. Interacts with beta-arrestin; CC this interaction is necessary for receptor internalization and is CC destabilized by heterodimerization with SSTR5 which results in CC increased recycling of SSTR2 to the cell surface. Interacts (via C- CC terminus) with SHANK1 (via PDZ domain) (By similarity). {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:8104154}; CC Multi-pass membrane protein {ECO:0000269|PubMed:8104154}. Cytoplasm CC {ECO:0000250}. Note=Located mainly at the cell surface under basal CC conditions. Agonist stimulation results in internalization to the CC cytoplasm (By similarity). {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=A; Synonyms=SS2RA; CC IsoId=P30875-1; Sequence=Displayed; CC Name=B; Synonyms=SS2RB; CC IsoId=P30875-2; Sequence=VSP_001923; CC -!- TISSUE SPECIFICITY: Cerebrum and kidney. CC -!- PTM: Phosphorylated on serine and threonine residues in response to CC agonist stimulation, leading to receptor desensitization and rapid CC internalization. Phosphorylated to a greater extent on serine than CC threonine residues. Threonine phosphorylation is required for arrestin CC binding and receptor endocytosis but is not necessary for CC desensitization (By similarity). {ECO:0000250}. CC -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family. CC {ECO:0000255|PROSITE-ProRule:PRU00521}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M81832; AAA58256.1; -; Genomic_DNA. DR EMBL; X68951; CAA48766.1; -; mRNA. DR EMBL; AF008914; AAD01419.1; -; Genomic_DNA. DR EMBL; AF008914; AAD01420.1; -; Genomic_DNA. DR EMBL; S71756; AAP20804.1; -; mRNA. DR CCDS; CCDS25598.1; -. [P30875-2] DR CCDS; CCDS59571.1; -. [P30875-1] DR PIR; D41795; D41795. DR PIR; S29248; S29248. DR RefSeq; NP_001036071.1; NM_001042606.2. [P30875-1] DR RefSeq; NP_033243.2; NM_009217.4. [P30875-2] DR AlphaFoldDB; P30875; -. DR SMR; P30875; -. DR IntAct; P30875; 2. DR MINT; P30875; -. DR STRING; 10090.ENSMUSP00000138101; -. DR BindingDB; P30875; -. DR ChEMBL; CHEMBL3207; -. DR DrugCentral; P30875; -. DR GuidetoPHARMACOLOGY; 356; -. DR GlyCosmos; P30875; 4 sites, No reported glycans. DR GlyGen; P30875; 4 sites. DR iPTMnet; P30875; -. DR PhosphoSitePlus; P30875; -. DR SwissPalm; P30875; -. DR PaxDb; 10090-ENSMUSP00000138101; -. DR ProteomicsDB; 257419; -. [P30875-1] DR ProteomicsDB; 257420; -. [P30875-2] DR ABCD; P30875; 20 sequenced antibodies. DR Antibodypedia; 1548; 455 antibodies from 37 providers. DR DNASU; 20606; -. DR Ensembl; ENSMUST00000067591.3; ENSMUSP00000068578.3; ENSMUSG00000047904.7. [P30875-2] DR Ensembl; ENSMUST00000106630.2; ENSMUSP00000102241.2; ENSMUSG00000047904.7. [P30875-2] DR Ensembl; ENSMUST00000146390.3; ENSMUSP00000138101.2; ENSMUSG00000047904.7. [P30875-1] DR GeneID; 20606; -. DR KEGG; mmu:20606; -. DR UCSC; uc007mep.2; mouse. [P30875-2] DR UCSC; uc011yha.2; mouse. [P30875-1] DR AGR; MGI:98328; -. DR CTD; 6752; -. DR MGI; MGI:98328; Sstr2. DR VEuPathDB; HostDB:ENSMUSG00000047904; -. DR eggNOG; KOG3656; Eukaryota. DR GeneTree; ENSGT00940000156544; -. DR HOGENOM; CLU_009579_8_1_1; -. DR InParanoid; P30875; -. DR OMA; YYDQTSN; -. DR OrthoDB; 5393360at2759; -. DR PhylomeDB; P30875; -. DR TreeFam; TF315737; -. DR Reactome; R-MMU-375276; Peptide ligand-binding receptors. DR Reactome; R-MMU-418594; G alpha (i) signalling events. DR BioGRID-ORCS; 20606; 3 hits in 75 CRISPR screens. DR ChiTaRS; Sstr2; mouse. DR PRO; PR:P30875; -. DR Proteomes; UP000000589; Chromosome 11. DR RNAct; P30875; Protein. DR Bgee; ENSMUSG00000047904; Expressed in skin of snout and 116 other cell types or tissues. DR GO; GO:0005829; C:cytosol; ISO:MGI. DR GO; GO:0016020; C:membrane; IDA:MGI. DR GO; GO:0043005; C:neuron projection; IBA:GO_Central. DR GO; GO:0005886; C:plasma membrane; IDA:MGI. DR GO; GO:0042923; F:neuropeptide binding; IBA:GO_Central. DR GO; GO:0030165; F:PDZ domain binding; ISO:MGI. DR GO; GO:0004994; F:somatostatin receptor activity; IDA:MGI. DR GO; GO:0007193; P:adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway; IDA:MGI. DR GO; GO:0071392; P:cellular response to estradiol stimulus; IBA:GO_Central. DR GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IBA:GO_Central. DR GO; GO:0021549; P:cerebellum development; IEA:Ensembl. DR GO; GO:0030900; P:forebrain development; IEA:Ensembl. DR GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:MGI. DR GO; GO:0007218; P:neuropeptide signaling pathway; IDA:MGI. DR GO; GO:0030432; P:peristalsis; ISO:MGI. DR GO; GO:0042594; P:response to starvation; IEA:Ensembl. DR GO; GO:0007283; P:spermatogenesis; IEA:Ensembl. DR CDD; cd15971; 7tmA_SSTR2; 1. DR Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1. DR InterPro; IPR000276; GPCR_Rhodpsn. DR InterPro; IPR017452; GPCR_Rhodpsn_7TM. DR InterPro; IPR000586; Somatstn_rcpt. DR InterPro; IPR002074; Somatstn_rcpt_2. DR PANTHER; PTHR24229; NEUROPEPTIDES RECEPTOR; 1. DR PANTHER; PTHR24229:SF6; SOMATOSTATIN RECEPTOR TYPE 2; 1. DR Pfam; PF00001; 7tm_1; 1. DR PRINTS; PR00237; GPCRRHODOPSN. DR PRINTS; PR00246; SOMATOSTATNR. DR PRINTS; PR00588; SOMATOSTTN2R. DR SMART; SM01381; 7TM_GPCR_Srsx; 1. DR SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1. DR PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1. DR PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1. DR Genevisible; P30875; MM. PE 2: Evidence at transcript level; KW Alternative splicing; Cell membrane; Cytoplasm; Disulfide bond; KW G-protein coupled receptor; Glycoprotein; Lipoprotein; Membrane; Palmitate; KW Phosphoprotein; Receptor; Reference proteome; Transducer; Transmembrane; KW Transmembrane helix. FT CHAIN 1..369 FT /note="Somatostatin receptor type 2" FT /id="PRO_0000070121" FT TOPO_DOM 1..43 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 44..67 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 68..78 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 79..103 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 104..118 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 119..138 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 139..161 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 162..181 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 182..207 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 208..229 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 230..253 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 254..278 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 279..288 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 289..303 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 304..369 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT MOD_RES 341 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P30680" FT MOD_RES 343 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P30680" FT MOD_RES 348 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P30680" FT MOD_RES 353 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P30680" FT MOD_RES 354 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P30680" FT LIPID 328 FT /note="S-palmitoyl cysteine" FT /evidence="ECO:0000255" FT CARBOHYD 9 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 22 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 29 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 32 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 115..193 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00521" FT VAR_SEQ 332..369 FT /note="VSGTEDGERSDSKQDKSRLNETTETQRTLLNGDLQTSI -> ADNSQSGAED FT IIAWV (in isoform B)" FT /evidence="ECO:0000305" FT /id="VSP_001923" FT CONFLICT 179 FT /note="I -> L (in Ref. 2; CAA48766)" FT /evidence="ECO:0000305" FT CONFLICT 305 FT /note="S -> T (in Ref. 2; CAA48766)" FT /evidence="ECO:0000305" SQ SEQUENCE 369 AA; 41222 MW; A78845AF74823039 CRC64; MEMSSEQLNG SQVWVSSPFD LNGSLGPSNG SNQTEPYYDM TSNAVLTFIY FVVCVVGLCG NTLVIYVILR YAKMKTITNI YILNLAIADE LFMLGLPFLA MQVALVHWPF GKAICRVVMT VDGINQFTSI FCLTVMSIDR YLAVVHPIKS AKWRRPRTAK MINVAVWCVS LLVILPIMIY AGLRSNQWGR SSCTINWPGE SGAWYTGFII YAFILGFLVP LTIICLCYLF IIIKVKSSGI RVGSSKRKKS EKKVTRMVSI VVAVFIFCWL PFYIFNVSSV SVAISPTPAL KGMFDFVVIL TYANSCANPI LYAFLSDNFK KSFQNVLCLV KVSGTEDGER SDSKQDKSRL NETTETQRTL LNGDLQTSI //